SCHEMBL6431056

SCHEMBL6431056

NC=CCNc1cccc(Nc2nccs2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.44
AURKA O14965 3/20 0.42
AURKB Q96GD4 1/20 0.42
ALDH1A1 P00352 6/20 0.39
CYP1A2 P05177 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
LMNA P02545 3/20 0.39
TDP1 Q9NUW8 3/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
GAA P10253 2/20 0.39
PKM P14618 2/20 0.39
CYP2C9 P11712 2/20 0.39
PIM1 P11309 1/20 0.39
CDK2 P24941 1/20 0.39
GSK3B P49841 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
NFKB1 P19838 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8906815 0.81 PLA2G7 (0.59) PLA2G7AURKAAURKBALDH1A1CYP1A2
SCHEMBL715948 0.74 PLA2G7 (0.52) PLA2G7AURKAAURKBALDH1A1CYP1A2
SCHEMBL4934858 0.74 FADS1 (0.30)
SCHEMBL27675533 0.73 PLA2G7 (0.49) PLA2G7AURKAAURKBALDH1A1CYP1A2
SCHEMBL716169 0.72 NPC1 (0.56) PLA2G7AURKAAURKBALDH1A1CYP1A2
SCHEMBL720796 0.72 PLA2G7 (0.45) PLA2G7AURKAAURKBALDH1A1CYP1A2
SCHEMBL3042388 0.71 MBD2 (0.55) PLA2G7AURKAALDH1A1CYP1A2MEN1
SCHEMBL3956903 0.71 MEN1 (0.65) PLA2G7ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL4238370 0.71 PLA2G7 (0.60) PLA2G7ALDH1A1CYP1A2MEN1KMT2A
SCHEMBL13548282 0.71 PLA2G7 (0.52) PLA2G7AURKAAURKBCYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050239852-A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors AB SCIENCE (FR) 2005-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050239852-A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors KIT, CHUK, MAP3K2 PLA2G7 2034/4885AURKA 117/4885AURKB 93/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.